Illinois Retina Associates

Recent papers from Illinois Retina Associates

1. The Hidden Economics of the Uveitis Specialist: A Practical Framework for Quantifying Direct, Downstream, and Strategic ContributionsOcular Immunology and Inflammation · 2026
2. Early Macular Leakage Resolution Is Associated with Extended Faricimab Dosing in Retinal Vein Occlusion: A BALATON/COMINO Post Hoc AnalysisOphthalmology and Therapy · 2026
3. CRX-related macular dystrophy phenocopying hydroxychloroquine toxicityEye · 2026
4. Four-Year Outcomes of Faricimab in Diabetic Macular Edema in the RHONE-X Extension Trial: A PodcastOphthalmology and Therapy · 2026
5. Early Versus Delayed Pegcetacoplan Treatment for Geographic Atrophy Secondary to Age-Related Macular Degeneration in OAKS, DERBY, and GALEAmerican Journal of Ophthalmology · 2026
6. Long-Term Outcomes of Laser Barricade for Large Rhegmatogenous Retinal DetachmentsJournal of VitreoRetinal Diseases · 2026
7. Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea studyScientific Reports · 2026
8. Effect of Intravitreal Anti-VEGF Injections on the Vitreomacular Interface in Treatment-Naïve Eyes With Central Retinal Vein OcclusionJournal of VitreoRetinal Diseases · 2026
9. Foreseeing the Unforeseeable: How U.S. Negligence Law Should Address the Foreseeability of Harms Caused by Autonomous AI AgentsJournal of Tort Law · 2026
10. Four-Year Outcomes of Faricimab in Diabetic Macular EdemaOphthalmology · 2026
11. Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience—ROSE Korea StudyScientific Reports · 2026
12. Geographic Atrophy Progression in Clinical Practice Before and After Pegcetacoplan TreatmentVision · 2025
13. Artificial Intelligence in Clinical Care: Perceptions of Retina Specialists and Patients Gathered Through a Multicenter SurveyJournal of VitreoRetinal Diseases · 2025
14. Artificial Intelligence in Clinical Care: Perceptions of Retina Specialists and Patients Gathered Through a Multicenter SurveyJournal of VitreoRetinal Diseases · 2025
15. Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings?Ophthalmology and Therapy · 2025
16. Timing of Epiretinal Membrane Surgery After Uncomplicated Retinal Detachment RepairJournal of VitreoRetinal Diseases · 2025
17. Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular DegenerationAmerican Journal of Ophthalmology · 2025
18. Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular EdemaJAMA Ophthalmology · 2025
19. The Heterogeneous Presentations of De Novo and Recurrent Ocular Inflammation After Covid-19 VaccinationRetina · 2025
20. Ophthalmic Manifestations in a Diverse Pediatric Population with Type I and Type II Stickler SyndromeOphthalmology Retina · 2024